HIRAL RAVAL: Open Payments
NPI 1306579354 · METUCHEN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,373 in 143 payments from 26 companies in 2025. Trend: 2023 $2,232 · 2024 $2,231 · 2025 $2,373
Food & beverage: $2,373
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 23 | $429 |
| Bayer Healthcare Pharmaceuticals Inc. | 16 | $312 |
| ABBVIE INC. | 13 | $199 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 17 | $196 |
| Amgen Inc. | 11 | $175 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $158 |
| Novo Nordisk Inc | 11 | $153 |
| GlaxoSmithKline, LLC. | 8 | $122 |
| Exact Sciences Corporation | 4 | $80 |
| Astellas Pharma US Inc | 4 | $79 |
Products named: BREZTRI, Kerendia, XIFAXAN, JARDIANCE, OTEZLA, SHINGRIX, UBRELVY, FARXIGA.
Industry payments across NJ — which companies pay providers there.
